Price is syncing
Reported smart-money activity is still available below.
Recent earnings
4/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
50 articles, 7 days
Analysts
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsWhat it reported, what was expected, and what comes next.
Reported Aug 4, 2026
Earnings per share
$0.68 expected
Revenue
$14.39B expected
GAAP EPS was -$0.04 and adjusted EPS was $0.77. The adjusted figure is comparable to consensus.
FY2026 guidance
$60.50B to $62.50B
No comparable estimate
Next report
EPS expected
$0.59 to $0.94
Revenue expected
16 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
From the release
The three statements, quarter by quarter.
Sep 2025 to Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| RevenueTotal revenue | $16.65B | $17.56B | $14.45B | $15.03B |
| Cost of what it soldCost of revenue | $4.17B | $5.27B | $4.73B | $4.09B |
| Gross profit | $12.48B | $12.29B | $9.72B | $10.94B |
| What it spent | ||||
| Research and development | $3.94B | $3.42B | $2.63B | $2.81B |
| Sales and adminSelling, general and administrative | $3.19B | $4.08B | $2.96B | $3.41B |
| Other operating costsOperating costs not itemised in the filing's summary | $1.81B | $1.10B | $100.0M | — |
| Total operating expenses | $8.93B | $8.60B | $5.69B | $6.24B |
| What was left | ||||
| Operating profitOperating income | $3.55B | $3.69B | $4.03B | $4.71B |
| Interest on debtInterest expense | $652.0M | $711.0M | $668.0M | $667.0M |
| Profit before tax | $3.33B | -$1.64B | $3.17B | -$653.0M |
| TaxIncome tax expense | -$216.0M | -$2.0M | $461.0M | -$407.0M |
| Net profitNet income | $3.54B | -$1.65B | $2.69B | -$246.0M |
| EBITDAEarnings before interest, tax, depreciation, amortisation | $5.65B | $756.0M | $5.02B | $1.20B |
Business quality, value, and expectations at a glance.
Fundamentals
Reasonably priced and running thin margins.
Valuation
Quality
Growth
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Politicians
Trend, range, and the price levels that matter.
Technicals
Technicals sync when verified market data is available. No sample data is shown.
Recent coverage and its overall tone.
News
Coverage is bullish
20 bullish · 29 neutral · 1 bearish
Tone of tracked coverage
Becton, Dickinson and Company (BDX) Stock forecasts
Leans bullishAug 11BNP Paribas Adjusts Price Target on AbbVie to $247 From $218, Maintains Neutral Rating
Leans bullishAug 11Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
Leans bullishAug 11With Bank of America at Record Highs, Wall Street Is Bullish but Retail Is Wary
Leans bullishAug 11Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
Leans bullishAug 11KMG Fiduciary Partners LLC Acquires 39,875 Shares of Pfizer Inc. $PFE
NeutralAug 11Keurig Dr Pepper Inc. (KDP) Stock Forecasts
NeutralAug 11Hawaiian Electric Industries, I (HE) Stock forecasts
NeutralAug 11$15K
sold
AlphaYou